Saranac Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$1.49M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$1.3M |
| 3 |
L3Harris
LHX
|
+$843K |
| 4 |
AbbVie
ABBV
|
+$788K |
| 5 |
HES
Hess
HES
|
+$679K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.09M |
| 2 |
TSMC
TSM
|
+$1.07M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$596K |
| 4 |
Microsoft
MSFT
|
+$486K |
| 5 |
State Street
STT
|
+$386K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.79% |
| 2 | Technology | 15.33% |
| 3 | Financials | 13.84% |
| 4 | Consumer Discretionary | 12.65% |
| 5 | Industrials | 8.15% |
Similar funds
Saranac Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Saranac Partners held 98 positions worth $189M, up 11% from $170M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Saranac Partners deployed $9.47M of net new capital in Q2 2023, opening 15 new positions and adding to 32 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 46,300 shares worth $1.26M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.09M trimmed.
- Saranac Partners's largest Q2 2023 buy was iShares China Large-Cap ETF: 46,300 shares worth $1.26M.
- Saranac Partners added most to Estee Lauder in Q2 2023, an estimated $1.49M increase.
- Saranac Partners's biggest Q2 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.09M.
- Saranac Partners fully exited State Street in Q2 2023, selling an estimated $386K.
- Saranac Partners's ten largest holdings make up 43% of its $189M portfolio in Q2 2023.
- Saranac Partners opened 15 new positions and closed 5 in Q2 2023.
- Saranac Partners's portfolio value rose 11% quarter-over-quarter to $189M.
Based on Saranac Partners's 13F filing for Q2 2023, filed 6 Feb 2026.